Drug Development

NovaVision Appoints Medical Technology Veteran Rudy Mazzocchi as Chief Executive Officer

Published in Cancer Weekly, July 1st, 2008

NovaVision announced the appointment of Rudy Mazzocchi as its new chief executive officer. In his role, Mazzocchi is responsible for leveraging the company's novel technology to find new channels of growth to ensure that patients with impaired vision have access to NovaVision(R) Vision Restoration Therapy (VRT).

Mazzocchi has 25 years of expertise bringing new medical technologies and devices to market that address unmet clinical needs. With extensive senior management, operational and financing experience, he has served as chief executive officer and founder of many medical technology or device companies.

Most recently, he served as Managing...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (2008-07-01)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry